和誉-B(02256):FGFR4抑制剂依帕戈替尼获FDA快速通道资格,用于治疗HCC患者
Last Update:
10 2 月, 2026
Please share this article if you like it!
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.